Aflatoxin G2

If corn, peanuts, or other grains are a regular part of your diet, a small amount of a mold-made poison can pass through your body and briefly appear in your urine. This test looks for one of those poisons.

A detectable result does not mean you are sick. It signals that your recent meals likely carried aflatoxin, a mold toxin whose main long-term concern is the liver.

What This Toxin Is and Where It Comes From

AFG2 (aflatoxin G2) is not something your body makes. It is one of four common aflatoxins, alongside B1, B2, and G1, produced by molds in the Aspergillus family. The G forms, including G2, come mainly from Aspergillus parasiticus and related species rather than from typical Aspergillus flavus strains, which tend to make only the B forms. These molds grow on crops before you ever eat them.

These molds thrive in warm, humid conditions and poor storage. The foods most often implicated are maize and corn products, groundnuts and peanuts, cereals, and other staples. Because the toxin enters your body through food, this test reflects dietary exposure, not an internal disease process.

This is a research-grade exposure marker rather than an established clinical test. There are no standardized cutoffs that tell you a level is safe or dangerous, so a single reading is best treated as a snapshot of recent exposure, not a diagnosis.

Recent Exposure, Not Long-Term Burden

Urine captures a short window. After aflatoxin is eaten, the body absorbs it quickly, and studies of the best-measured aflatoxin, AFB1 (aflatoxin B1), show that urinary aflatoxin markers are cleared rapidly, largely within about a day.

That speed matters for how you read a result. A positive urine sample points to intake over the past day or few days. A negative sample can still miss exposure that happened last week or that comes and goes with your diet.

To capture longer-term exposure, researchers turn to a different measurement in blood: aflatoxin bound to the protein albumin, which reflects intake over the prior weeks because albumin itself lasts about 20 days in the body. Urine and blood answer different questions, and this urine test speaks only to recent exposure.

The Liver Cancer Connection

The strongest reason anyone cares about aflatoxins is liver cancer, known medically as hepatocellular carcinoma (a cancer that starts in the liver). Here the identity of the specific toxin matters. The clearest cancer evidence points to AFB1, and the human studies below tracked urinary or blood markers of AFB1, not aflatoxin G2 specifically.

A long-running study of 18,244 men in Shanghai found that men with detectable urinary AFB1 markers had a higher risk of later developing liver cancer, and that risk multiplied when they also carried chronic HBV (hepatitis B virus) infection. In a related analysis, people with high urinary aflatoxin plus hepatitis B were far more likely to develop liver cancer than people with low aflatoxin and no hepatitis B, with risk estimates ranging from modest to many times higher depending on the comparison.

For aflatoxin G2 itself, the direct cancer evidence is weak. Reviews classify AFB1 and AFG1 as having clearer cancer-causing evidence, while the evidence for AFB2 is limited and, for AFG2, international reviewers have described the evidence as inadequate, an even weaker category. This is not a contradiction to resolve so much as a matter of framing: aflatoxin G2 is a member of a chemical family that includes potent carcinogens, and it flags that carcinogenic aflatoxins are entering your diet, but on its own it carries weaker direct evidence than its better-studied relatives. Treat a positive result as a prompt to reduce exposure to the whole family, not as proof of personal cancer risk.

Acute Poisoning and Other Effects

At very high doses, aflatoxins can cause acute poisoning, called aflatoxicosis, with vomiting, abdominal pain, jaundice, fluid buildup, and in severe outbreaks, liver failure and death. A review of acute aflatoxicosis reported death rates ranging from 16.2% to 76.5% across outbreaks, hitting children under 15 and adults over 40 hardest. These events involve heavily contaminated food, not the low-level exposures typical of routine diets.

Beyond the liver, chronic aflatoxin exposure has been linked in human studies to immune suppression, impaired growth in children, cirrhosis, and, in newer case-control work, gallbladder cancer. In one study, detectable aflatoxin-albumin markers in blood were an independent risk factor for gallbladder cancer, with roughly seven times the odds, though that estimate came with a wide margin of uncertainty. As with liver cancer, these associations come from aflatoxin exposure broadly and from AFB1 markers, not from urinary aflatoxin G2 specifically.

Why This Toxin Shows Up Rarely

Urinary aflatoxin G2 is detected infrequently and inconsistently, which shapes how you should read a negative result. It appears in a minority of samples across most human studies, and a different aflatoxin, AFM1, is found far more often.

Source line: Portugal biomonitoring (Martins et al., 2020); Italian workers (Ferri et al., 2017); Sao Paulo (Jager et al., 2014).

What this means for you: a negative result is reassuring about recent heavy exposure but does not rule out intermittent exposure, because a rarely detected marker measured in a single sample can easily miss it. The value of this test grows when you look at it over time and alongside other markers, not from any one reading.

Tracking Your Trend

Because urinary aflatoxin reflects only the last day or few days and varies with each meal, a single number tells you little. A pattern tells you much more. If you are changing where your food comes from or how it is stored, repeat testing lets you see whether exposure is actually falling rather than guessing.

A reasonable approach is to get a baseline, retest after a few months if you are making dietary or food-sourcing changes, and check periodically after that. Space the sample away from any single unusual meal so the result reflects your typical diet rather than one contaminated item.

One honesty note about trending: the human trials showing that specific interventions lower aflatoxin markers measured other aflatoxins, such as AFM1 and AFB1-DNA fragments, not aflatoxin G2. So if you retest hoping to confirm an intervention is working, know that the direct evidence tying those interventions to this exact marker is thin. The most dependable driver of your number is simply how much contaminated food you have eaten recently.

When Results Can Be Misleading

Several things can distort a single reading and lead you to the wrong conclusion:

• Timing of your last meal: because urinary aflatoxin clears within roughly a day, a sample taken soon after a contaminated meal can look high while one taken days later looks clean, even with the same overall diet.
• Urine concentration: how hydrated you are dilutes or concentrates the sample, which is why labs often adjust results to urinary creatinine, a marker of urine concentration.
• A rarely detected marker: aflatoxin G2 shows up in only a small fraction of samples, so a single non-detection is weak evidence of no exposure over the longer term.
• Wrong tool for chronic exposure: urine reflects recent intake only, so it can under-represent someone with steady, low-level exposure whose burden would show better on a blood aflatoxin-albumin test.

What to Do With an Unexpected Result

A detectable result is a signal to look at two things together: your exposure and your liver. On the exposure side, review your staple foods, their source, and how they are stored, then retest after making changes to see whether the number falls.

On the health side, the pattern that warrants more attention is a positive aflatoxin result combined with a liver risk factor. If you carry chronic hepatitis B or hepatitis C, or have any existing liver disease, the combination matters more than the toxin alone, and it is worth involving a clinician who manages liver health, such as a hepatologist, or a toxicologist. Sensible companion tests to order alongside this one include liver enzymes such as ALT (alanine aminotransferase) and AST (aspartate aminotransferase), hepatitis B status, and, in higher-risk situations, alpha-fetoprotein, a blood marker used in liver cancer surveillance. A blood aflatoxin-albumin measurement can extend the exposure window if you want a longer-term picture. Decisions here rest on the combination of findings, not on crossing any single number.